The AEterna Zentaris Inc. (AEZS) Trading -5.2% Higher After Analyst Upgrade

The AEterna Zentaris Inc. (AEZS) Trading -5.2% Higher  After Analyst Upgrade

Shares of AEterna Zentaris Inc. (NASDAQ:AEZS) (TSE:AEZ) shot up 5.2% during mid-day trading on Wednesday after Maxim Group raised their price target on the stock from $7.00 to $10.00. Maxim Group currently has a buy rating on the stock. AEterna Zentaris traded as high as $3.10 and last traded at $2.75, with a volume of 389,816 shares traded. The stock had previously closed at $2.90.

Other analysts also recently issued reports about the company. Canaccord Genuity set a $6.00 price target on AEterna Zentaris and gave the stock a “buy” rating in a research report on Sunday, January 8th. HC Wainwright restated a “buy” rating and issued a $12.00 price target on shares of AEterna Zentaris in a research report on Sunday, November 20th. Finally, Zacks Investment Research downgraded AEterna Zentaris from a “buy” rating to a “hold” rating in a research report on Tuesday, October 11th.

The firm has a 50 day moving average of $3.43 and a 200-day moving average of $3.55. The firm’s market capitalization is $31.51 million.

AEterna Zentaris Company Profile

Aeterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and women’s health. The Company operates through the biopharmaceutical segment. The Company is engaged in drug development activities and in the promotion of products for others.

Related posts

Leave a Comment